Question 1

What is the Medical Device Division (MDD) and why is it important?

Accepted Answer

The Medical Device Division (MDD) is part of Hong Kong's Department of Health responsible for medical device regulation and safety oversight. Hong Kong is transitioning from the voluntary Medical Device Administrative Control System (MDAC) to a mandatory Medical Device Control System (MDCS), which will establish comprehensive pre-market and post-market requirements. Under MDCS, manufacturers will need to register devices, designate Local Responsible Persons, and comply with quality management requirements. The transition aligns Hong Kong with international best practices while maintaining its role as a healthcare hub in Asia.

Question 2

What is MDAC and what is MDCS?

Accepted Answer

MDAC (Medical Device Administrative Control System): Current voluntary listing system, manufacturers can voluntarily list devices to demonstrate quality, provides market credibility but not legally mandatory. MDCS (Medical Device Control System): New mandatory regulatory system under development/implementation, requires pre-market approval or notification for all device classes, mandatory Local Responsible Person designation, quality management system requirements (ISO 13485), post-market surveillance and adverse event reporting, enforcement mechanisms and penalties for non-compliance. Timeline: MDCS legislation passed, implementation phased by device class (Class III/IV first, followed by Class II, then Class I). Manufacturers should prepare for MDCS transition by ensuring ISO 13485 certification and identifying Local Responsible Persons.

Question 3

How does Hong Kong classify medical devices under MDCS?

Accepted Answer

Hong Kong adopts a risk-based classification system under MDCS aligned with international frameworks (similar to EU MDR and GHTF): Class I: Low risk (e.g., non-invasive devices, surgical instruments), Class II: Medium risk (e.g., short-term invasive, some active devices), Class III: Medium-high risk (e.g., long-term invasive, critical diagnostic), Class IV: High risk (e.g., implantable, life-sustaining, drug-device combinations). Classification is based on: invasiveness, duration of use, whether device is active, intended purpose and critical nature, interaction with circulatory system or central nervous system. Higher class devices require more extensive pre-market review and conformity assessment.

Question 4

What is a Local Responsible Person and will it be required?

Accepted Answer

A Local Responsible Person (LRP) is a natural or legal person established in Hong Kong designated by a manufacturer to act as their regulatory representative. Under the MDCS framework: Requirements: Must be domiciled in Hong Kong, registered with MDD, Responsibilities: Submit device registration or notification applications, maintain technical documentation and conformity certificates, serve as liaison between manufacturer and MDD, handle post-market surveillance and adverse event reporting, coordinate recalls and corrective actions. Mandatory Status: LRP will be required for all manufacturers (including those based outside Hong Kong) under MDCS. Foreign manufacturers should identify potential LRP partners in advance of MDCS implementation for their device classes.

Question 5

What are the quality management system requirements under MDCS?

Accepted Answer

MDCS will require manufacturers to demonstrate compliance with quality management system standards: Primary Standard: ISO 13485 certification (internationally recognized and preferred), Acceptable Alternatives: CE marking certificate (demonstrates ISO 13485 compliance), FDA QSR compliance, MDSAP audit reports, other internationally recognized QMS certificates. Certificate Requirements: Must be current and valid, issued by accredited certification body, cover the specific manufacturing site(s), include device models being registered. Conformity Assessment: Higher class devices (III/IV) will require third-party conformity assessment, recognition of EU Notified Body and other international certifications expected. Manufacturers without ISO 13485 should obtain certification to prepare for MDCS.

Question 6

What is the current status of MDCS implementation?

Accepted Answer

Hong Kong passed the Medical Devices Ordinance establishing MDCS, with phased implementation underway: Implementation Timeline: Class III/IV devices: First phase (implementation started or imminent), Class II devices: Second phase (following Class III/IV), Class I devices: Final phase, IVDs: Separate timeline under consideration. Transition Provisions: Devices currently on the market may have grace periods, manufacturers should register early to avoid supply interruption, MDAC voluntary listing remains available during transition. Current Actions for Manufacturers: Obtain or verify ISO 13485 certification, identify and engage Local Responsible Person in Hong Kong, prepare technical documentation and conformity certificates, monitor MDD announcements for specific implementation dates for your device class.

Question 7

How often is Hong Kong medical device regulatory news updated and how can I stay informed?

Accepted Answer

The Medical Device Division regularly publishes updates on MDCS implementation, guidance documents, and regulatory timelines. With the transition from MDAC to MDCS ongoing, manufacturers should closely monitor developments. Our platform aggregates daily updates from 7 premium commercial sources including RAPS, Emergo by UL, Asia Actual, and Citeline. We recommend checking this page regularly and consulting with your Local Responsible Person or regulatory advisors for the latest MDCS timelines and requirements.

Question 8

What commercial sources does this platform use for Hong Kong news?

Accepted Answer

We aggregate Hong Kong regulatory intelligence from 7 premium sources: RAPS (Regulatory Affairs Professionals Society), Emergo by UL, Citeline MedTech Insight, Pacific Bridge Medical, Asia Actual, Pure Global's proprietary research, and Qualtechs. These sources provide expert analysis, real-time updates, and strategic insights beyond basic MDD announcements, helping you navigate MDCS transition, Local Responsible Person designation, registration timelines, and quality certification requirements.

Hong Kong MDD Medical Device News 2025: Registration & Regulatory Updates | Pure Global

Frequently Asked Questions About MDD News